Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R5147 SCR-F | ||
| By: Jones of Dallas | H.B. No. 4674 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to modification of certain prescription drug benefits and | |
| coverage offered by certain health benefit plans. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 1369.053, Insurance Code, as effective | |
| April 1, 2025, is amended to read as follows: | |
| Sec. 1369.053. EXCEPTION. This subchapter does not apply | |
| to: | |
| (1) a health benefit plan that provides coverage: | |
| (A) only for a specified disease or for another | |
| single benefit; | |
| (B) only for accidental death or dismemberment; | |
| (C) for wages or payments in lieu of wages for a | |
| period during which an employee is absent from work because of | |
| sickness or injury; | |
| (D) as a supplement to a liability insurance | |
| policy; | |
| (E) for credit insurance; | |
| (F) only for dental or vision care; | |
| (G) only for hospital expenses; or | |
| (H) only for indemnity for hospital confinement; | |
| (2) a Medicare supplemental policy as defined by | |
| Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss), | |
| as amended; | |
| (3) a workers' compensation insurance policy; | |
| (4) medical payment insurance coverage provided under | |
| a motor vehicle insurance policy; | |
| (5) a long-term care insurance policy, including a | |
| nursing home fixed indemnity policy, unless the commissioner | |
| determines that the policy provides benefit coverage so | |
| comprehensive that the policy is a health benefit plan as described | |
| by Section 1369.052; | |
| (6) the child health plan program under Chapter 62, | |
| Health and Safety Code, or the health benefits plan for children | |
| under Chapter 63, Health and Safety Code; [ |
|
| (7) a Medicaid managed care program operated under | |
| Chapter 540 or 540A, Government Code, as applicable, or a Medicaid | |
| program operated under Chapter 32, Human Resources Code; or | |
| (8) a self-funded health benefit plan as defined by | |
| the Employee Retirement Income Security Act of 1974 (29 U.S.C. | |
| Section 1001 et seq.). | |
| SECTION 2. Section 1369.0541, Insurance Code, is amended by | |
| amending Subsections (a) and (b) and adding Subsections (a-1) and | |
| (b-1) to read as follows: | |
| (a) Except as provided by Section 1369.055(a-1) and | |
| Subsection (b-1) of this section, a [ |
|
| may modify drug coverage provided under a health benefit plan if: | |
| (1) the modification occurs at the time of coverage | |
| renewal; | |
| (2) the modification is effective uniformly among all | |
| group health benefit plan sponsors covered by identical or | |
| substantially identical health benefit plans or all individuals | |
| covered by identical or substantially identical individual health | |
| benefit plans, as applicable; and | |
| (3) not later than the 60th day before the date the | |
| modification is effective, the issuer provides written notice of | |
| the modification to the commissioner, each affected group health | |
| benefit plan sponsor, each affected enrollee in an affected group | |
| health benefit plan, and each affected individual health benefit | |
| plan holder. | |
| (a-1) The notice described by Subsection (a)(3) must | |
| include a statement: | |
| (1) indicating that the health benefit plan issuer is | |
| modifying drug coverage provided under the health benefit plan; | |
| (2) explaining the type of modification; and | |
| (3) indicating that, on renewal of the health benefit | |
| plan, the health benefit plan issuer may not modify an enrollee's | |
| contracted benefit level for any prescription drug that was | |
| approved or covered under the plan in the immediately preceding | |
| plan year as provided by Section 1369.055(a-1). | |
| (b) Modifications affecting drug coverage that require | |
| notice under Subsection (a) include: | |
| (1) removing a drug from a formulary; | |
| (2) adding a requirement that an enrollee receive | |
| prior authorization for a drug; | |
| (3) imposing or altering a quantity limit for a drug; | |
| (4) imposing a step-therapy restriction for a drug; | |
| [ |
|
| (5) moving a drug to a higher cost-sharing tier; | |
| (6) increasing a coinsurance, copayment, deductible, | |
| or other out-of-pocket expense that an enrollee must pay for a drug; | |
| and | |
| (7) reducing the maximum drug coverage amount [ |
|
| (b-1) Modifications affecting drug coverage that are more | |
| favorable to enrollees may be made at any time and do not require | |
| notice under Subsection (a), including: | |
| (1) the addition of a drug to a formulary; | |
| (2) the reduction of a coinsurance, copayment, | |
| deductible, or other out-of-pocket expense that an enrollee must | |
| pay for a drug; and | |
| (3) the removal of a utilization review requirement. | |
| SECTION 3. Section 1369.055, Insurance Code, is amended by | |
| adding Subsections (a-1), (a-2), and (c) to read as follows: | |
| (a-1) On renewal of a health benefit plan, the plan issuer | |
| may not modify an enrollee's contracted benefit level for any | |
| prescription drug that was approved or covered under the plan in the | |
| immediately preceding plan year and prescribed during that year for | |
| a medical condition or mental illness of the enrollee if: | |
| (1) the enrollee was covered by the health benefit | |
| plan on the date immediately preceding the renewal date; | |
| (2) a physician or other prescribing provider | |
| prescribes the drug for the medical condition or mental illness; | |
| and | |
| (3) the physician or other prescribing provider in | |
| consultation with the enrollee determines that the drug is the most | |
| appropriate course of treatment. | |
| (a-2) Modifications prohibited under Subsection (a-1) | |
| include: | |
| (1) removing a drug from a formulary; | |
| (2) adding a requirement that an enrollee receive | |
| prior authorization for a drug; | |
| (3) imposing or altering a quantity limit for a drug; | |
| (4) imposing a step-therapy restriction for a drug; | |
| (5) moving a drug to a higher cost-sharing tier; | |
| (6) increasing a coinsurance, copayment, deductible, | |
| or other out-of-pocket expense that an enrollee must pay for a drug; | |
| and | |
| (7) reducing the maximum drug coverage amount. | |
| (c) Subsections (a-1) and (a-2) do not: | |
| (1) prohibit a health benefit plan issuer from | |
| requiring, by contract, written policy or procedure, or other | |
| agreement or course of conduct, a pharmacist to provide a | |
| substitution for a prescription drug in accordance with Subchapter | |
| A, Chapter 562, Occupations Code, under which the pharmacist may | |
| substitute an interchangeable biologic product or therapeutically | |
| equivalent generic product as determined by the United States Food | |
| and Drug Administration; | |
| (2) prohibit a physician or other prescribing provider | |
| from prescribing another medication; | |
| (3) prohibit the health benefit plan issuer from | |
| adding a new drug to a formulary; | |
| (4) require a health benefit plan to provide coverage | |
| to an enrollee under circumstances not described by Subsection | |
| (a-1); or | |
| (5) prohibit a health benefit plan issuer from | |
| removing a drug from its formulary or denying an enrollee coverage | |
| for the drug if: | |
| (A) the United States Food and Drug | |
| Administration has issued a statement about the drug that calls | |
| into question the clinical safety of the drug; | |
| (B) the drug manufacturer has notified the United | |
| States Food and Drug Administration of a manufacturing | |
| discontinuance or potential discontinuance of the drug as required | |
| by Section 506C, Federal Food, Drug, and Cosmetic Act (21 U.S.C. | |
| Section 356c); or | |
| (C) the drug manufacturer has removed the drug | |
| from the market. | |
| SECTION 4. The changes in law made by this Act apply only to | |
| a health benefit plan that is delivered, issued for delivery, or | |
| renewed on or after January 1, 2026. A health benefit plan | |
| delivered, issued for delivery, or renewed before January 1, 2026, | |
| is governed by the law as it existed immediately before the | |
| effective date of this Act, and that law is continued in effect for | |
| that purpose. | |
| SECTION 5. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.